However, by year-end India is likely to have more than half a dozen COVID-19 vaccines. COVOVAXPune-based Serum Institute of India (SII) is also producing protein-based COVID-19 vaccine NVX-CoV2373 under the brand name 'Covovax'. HGC019Pune-based Gennova Biopharmaceuticals has developed India's first mRNA COVID-19 vaccine called HGC019. ZyCoV-DZydus Cadila in Gujarat is producing an intradermal COVID-19 vaccine called ZyCoV-D. The government said it will make an advance payment of Rs 1,500 crore to Biological E to reserve 30 crore doses of Corbevax.

Source: dna June 05, 2021 11:56 UTC